| Mutational landscape and significance across 12 major cancer types C Kandoth, MD McLellan, F Vandin, K Ye, B Niu, C Lu, M Xie, Q Zhang, ... Nature 502 (7471), 333-339, 2013 | 4906 | 2013 |
| Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing L Ding, TJ Ley, DE Larson, CA Miller, DC Koboldt, JS Welch, JK Ritchey, ... Nature 481 (7382), 506-510, 2012 | 2577 | 2012 |
| DNMT3A Mutations in Acute Myeloid Leukemia TJ Ley, L Ding, MJ Walter, MD McLellan, T Lamprecht, DE Larson, ... New England Journal of Medicine 363 (25), 2424-2433, 2010 | 2453 | 2010 |
| Age-related mutations associated with clonal hematopoietic expansion and malignancies M Xie, C Lu, J Wang, MD McLellan, KJ Johnson, MC Wendl, ... Nature medicine 20 (12), 1472-1478, 2014 | 2007 | 2014 |
| The origin and evolution of mutations in acute myeloid leukemia JS Welch, TJ Ley, DC Link, CA Miller, DE Larson, DC Koboldt, ... Cell 150 (2), 264-278, 2012 | 1883 | 2012 |
| 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signaling pathway DS Straus, G Pascual, M Li, JS Welch, M Ricote, CH Hsiang, ... Proceedings of the National Academy of Sciences 97 (9), 4844-4849, 2000 | 1324 | 2000 |
| Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase JT Huang, JS Welch, M Ricote, CJ Binder, TM Willson, C Kelly, JL Witztum, ... Nature 400 (6742), 378-382, 1999 | 1117 | 1999 |
| Expression of the peroxisome proliferator-activated receptor γ (PPARγ) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low … M Ricote, J Huang, L Fajas, A Li, J Welch, J Najib, JL Witztum, J Auwerx, ... Proceedings of the National Academy of Sciences 95 (13), 7614-7619, 1998 | 940 | 1998 |
| Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia TN Wong, G Ramsingh, AL Young, CA Miller, W Touma, JS Welch, ... Nature 518 (7540), 552-555, 2015 | 866 | 2015 |
| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 857 | 2016 |
| PPARγ and PPARδ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages JS Welch, M Ricote, TE Akiyama, FJ Gonzalez, CK Glass Proceedings of the National Academy of Sciences 100 (11), 6712-6717, 2003 | 573 | 2003 |
| SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution CA Miller, BS White, ND Dees, M Griffith, JS Welch, OL Griffith, R Vij, ... PLoS computational biology 10 (8), e1003665, 2014 | 510 | 2014 |
| Immune escape of relapsed AML cells after allogeneic transplantation MJ Christopher, AA Petti, MP Rettig, CA Miller, E Chendamarai, ... New England Journal of Medicine 379 (24), 2330-2341, 2018 | 424 | 2018 |
| The peroxisome proliferator‐activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function M Ricote, JT Huang, JS Welch, CK Glass Journal of leukocyte biology 66 (5), 733-739, 1999 | 402 | 1999 |
| Association between mutation clearance after induction therapy and outcomes in acute myeloid leukemia JM Klco, CA Miller, M Griffith, A Petti, DH Spencer, S Ketkar-Kulkarni, ... Jama 314 (8), 811-822, 2015 | 393 | 2015 |
| Patterns and functional implications of rare germline variants across 12 cancer types C Lu, M Xie, MC Wendl, J Wang, MD McLellan, MDM Leiserson, K Huang, ... Nature communications 6 (1), 10086, 2015 | 316 | 2015 |
| TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism JS Welch, L Escoubet-Lozach, DB Sykes, K Liddiard, DR Greaves, ... Journal of Biological Chemistry 277 (45), 42821-42829, 2002 | 315 | 2002 |
| Use of whole-genome sequencing to diagnose a cryptic fusion oncogene JS Welch, P Westervelt, L Ding, DE Larson, JM Klco, S Kulkarni, J Wallis, ... Jama 305 (15), 1577-1584, 2011 | 304 | 2011 |
| Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia JE Churpek, K Pyrtel, KL Kanchi, J Shao, D Koboldt, CA Miller, D Shen, ... Blood, The Journal of the American Society of Hematology 126 (22), 2484-2490, 2015 | 276 | 2015 |
| 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial CD DiNardo, A Maiti, CR Rausch, N Pemmaraju, K Naqvi, NG Daver, ... The Lancet Haematology 7 (10), e724-e736, 2020 | 275 | 2020 |
